Medunik Canada Inc. Ruzurgi product image Ruzurgi® (amifampidine), indicated for the symptomatic treatment of Lambert-Eaton Myasthenic Syndrome (LEMS) in patients 6 years of age and older, is an oral potassium channel inhibitor designed to prolong signals released by nerves to allow greater muscle stimulation. BLAINVILLE, Quebec, January 17, 2023 (GLOBE NEWSWIRE) — Medunik Canada Inc. […]